Sales 2024 by Business Segment

Sales 2024 by Geography

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Geographical Revenue Distribution History

Breakdown by Business Segment (USD)
Fiscal Period: December 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Pharmaceutical Products

          

Discovering, Developing and Commercializing Drugs

22.81M 83.8M 250M 464M 681M

Total Assets

717M 490M 755M 728M 1.37B

Interest Expense

- - - - -

Income Tax Expense

13.51K 5.63K 6K 636K 473K

CAPEX

-267K -326K -778K -269K -322K

EBT

-227M -284M -256M -139M -74.2M

D&A

528K 533K 656K 528K 508K

Operating Income

-231M -286M -264M -159M -117M

Net Income

-227M -284M -256M -140M -74.68M
Geographical breakdown of sales (USD)
Fiscal Period: December 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

United States

- 83.8M 250M 464M 681M

Total Assets

- 490M 755M 728M 1.37B

Interest Expense

- - - - -

Income Tax Expense

- 5.63K 6K 636K 473K

D&A

- 533K 656K 528K 508K

CAPEX

- -326K -778K -269K -322K

Net Income

- -284M -256M -140M -74.68M

EBT

- -284M -256M -139M -74.2M

Operating Income

- -286M -264M -159M -117M